Emerging advances in hydrogel-based therapeutic strategies for tissue regeneration.

3D-bioprinting Cells therapies Growth factors Hydrogel Tissue engineering

Journal

Regenerative therapy
ISSN: 2352-3204
Titre abrégé: Regen Ther
Pays: Netherlands
ID NLM: 101709085

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 17 04 2023
revised: 14 08 2023
accepted: 07 09 2023
medline: 29 9 2023
pubmed: 29 9 2023
entrez: 29 9 2023
Statut: epublish

Résumé

Significant developments in cell therapy and biomaterial science have broadened the therapeutic landscape of tissue regeneration. Tissue damage is a complex biological process in which different types of cells play a specific role in repairing damaged tissues and growth factors strictly regulate the activity of these cells. Hydrogels have become promising biomaterials for tissue regeneration if appropriate materials are selected and the hydrogel properties are well-regulated. Importantly, they can be used as carriers for living cells and growth factors due to the high water-holding capacity, high permeability, and good biocompatibility of hydrogels. Cell-loaded hydrogels can play an essential role in treating damaged tissues and open new avenues for cell therapy. There is ample evidence substantiating the ability of hydrogels to facilitate the delivery of cells (stem cell, macrophage, chondrocyte, and osteoblast) and growth factors (bone morphogenetic protein, transforming growth factor, vascular endothelial growth factor and fibroblast growth factor). This paper reviewed the latest advances in hydrogels loaded with cells or growth factors to promote the reconstruction of tissues. Furthermore, we discussed the shortcomings of the application of hydrogels in tissue engineering to promote their further development.

Identifiants

pubmed: 37772128
doi: 10.1016/j.reth.2023.09.007
pii: S2352-3204(23)00089-5
pmc: PMC10523184
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

459-471

Informations de copyright

© 2023 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

Small. 2018 Jul 6;:e1703509
pubmed: 29978547
Int J Nanomedicine. 2022 Dec 09;17:6201-6220
pubmed: 36531118
Acta Biomater. 2017 Jul 15;57:1-25
pubmed: 28088667
Int J Biol Macromol. 2020 Dec 1;164:667-676
pubmed: 32682043
Biomaterials. 2021 Nov;278:121131
pubmed: 34543785
Biomaterials. 2020 May;240:119841
pubmed: 32088411
Int J Mol Sci. 2021 Jun 22;22(13):
pubmed: 34206294
Tissue Eng Regen Med. 2023 Feb;20(1):143-154
pubmed: 36482140
Acta Biomater. 2019 Jan 1;83:167-176
pubmed: 30458242
Int J Mol Sci. 2022 Jan 15;23(2):
pubmed: 35055112
Int J Biol Macromol. 2021 Jan 15;167:796-806
pubmed: 33278440
Cytokine Growth Factor Rev. 2021 Dec;62:94-104
pubmed: 34593304
Biomaterials. 2020 Feb;230:119627
pubmed: 31767445
Adv Funct Mater. 2020 Sep 10;30(37):
pubmed: 32952493
Mater Sci Eng C Mater Biol Appl. 2019 Dec;105:110118
pubmed: 31546362
Mater Today Bio. 2022 Dec 21;18:100522
pubmed: 36593913
Int J Biol Macromol. 2020 Dec 1;164:1960-1972
pubmed: 32800960
Annu Rev Med. 2017 Jan 14;68:29-40
pubmed: 27732788
J Tissue Eng Regen Med. 2021 Nov;15(11):936-947
pubmed: 34388313
Acta Biomater. 2019 Jul 15;93:210-221
pubmed: 30685477
Mater Sci Eng C Mater Biol Appl. 2020 Nov;116:111165
pubmed: 32806308
Int J Nanomedicine. 2018 Sep 24;13:5637-5655
pubmed: 30288038
Mater Sci Eng C Mater Biol Appl. 2021 Feb;119:111604
pubmed: 33321648
Cells. 2021 Jul 23;10(8):
pubmed: 34440641
Adv Healthc Mater. 2020 May;9(10):e2000041
pubmed: 32338466
Pharmaceutics. 2020 Oct 22;12(11):
pubmed: 33105857
J Control Release. 2007 Apr 2;118(2):169-76
pubmed: 17289206
Int J Biol Macromol. 2018 Oct 15;118(Pt B):1648-1654
pubmed: 29981331
Bioact Mater. 2021 Mar 11;6(10):3218-3230
pubmed: 33778200
Chem Commun (Camb). 2019 Jan 10;55(5):699-702
pubmed: 30565595
Int J Biol Macromol. 2021 Jul 31;183:435-446
pubmed: 33932420
Colloids Surf B Biointerfaces. 2018 Mar 1;163:336-345
pubmed: 29331905
Small. 2020 Dec;16(50):e2005433
pubmed: 33230977
Front Bioeng Biotechnol. 2022 Mar 30;10:829969
pubmed: 35433655
Front Bioeng Biotechnol. 2021 Oct 19;9:755964
pubmed: 34738008
Nat Commun. 2020 Mar 13;11(1):1365
pubmed: 32170076
Front Bioeng Biotechnol. 2020 Nov 27;8:604814
pubmed: 33330436
Biomater Sci. 2020 Jun 21;8(12):3454-3471
pubmed: 32420550
Biomaterials. 2018 Oct;180:143-162
pubmed: 30036727
Acta Biomater. 2021 Jul 1;128:1-20
pubmed: 33746032
Acta Biomater. 2020 Mar 15;105:44-55
pubmed: 32035282
Biomaterials. 2020 Feb;232:119645
pubmed: 31865192
Sci Signal. 2019 Feb 26;12(570):
pubmed: 30808818
Front Bioeng Biotechnol. 2021 Jul 01;9:688467
pubmed: 34277588
Acta Biomater. 2020 Sep 15;114:170-182
pubmed: 32771588
Bioact Mater. 2021 Apr 18;6(11):3976-3986
pubmed: 33997487
Eur J Pharmacol. 2022 Mar 5;918:174657
pubmed: 34871557
Signal Transduct Target Ther. 2021 Dec 16;6(1):426
pubmed: 34916490
Stem Cell Res Ther. 2019 Apr 27;10(1):126
pubmed: 31029166
Stem Cell Res Ther. 2017 Sep 5;8(1):193
pubmed: 28874184
Laryngoscope. 2018 Jul;128(7):E251-E257
pubmed: 29668079
Adv Sci (Weinh). 2021 Aug;8(15):e2100805
pubmed: 34050637
Adv Sci (Weinh). 2017 Nov 24;5(3):1700550
pubmed: 29593958
Drug Deliv. 2021 Dec;28(1):319-324
pubmed: 33517806
PLoS One. 2019 Jan 10;14(1):e0210285
pubmed: 30629660
Carbohydr Polym. 2020 Sep 15;244:116479
pubmed: 32536384
Int J Nanomedicine. 2021 Aug 16;16:5603-5619
pubmed: 34429602
Adv Drug Deliv Rev. 2022 Jul;186:114326
pubmed: 35588953
Stem Cell Res Ther. 2020 Oct 6;11(1):433
pubmed: 33023631
J Mater Chem B. 2021 Sep 15;9(35):7132-7139
pubmed: 33998629
Adv Healthc Mater. 2019 Nov;8(22):e1901103
pubmed: 31609095
ACS Biomater Sci Eng. 2020 Sep 14;6(9):5096-5109
pubmed: 33455261
J Control Release. 2019 Jul 28;306:40-58
pubmed: 31150750
Front Bioeng Biotechnol. 2019 Sep 25;7:231
pubmed: 31681736
J Control Release. 2020 Nov 10;327:747-765
pubmed: 32941931
J Biomed Mater Res A. 2020 Nov 1;108(11):2240-2250
pubmed: 32363683
Biomaterials. 2018 Jun;168:38-53
pubmed: 29614431
Int J Mol Sci. 2020 Dec 18;21(24):
pubmed: 33352826
Biofabrication. 2019 Jul 01;11(4):044101
pubmed: 31151123
Mater Sci Eng C Mater Biol Appl. 2019 Nov;104:110002
pubmed: 31499949
Cold Spring Harb Perspect Biol. 2017 Apr 3;9(4):
pubmed: 27920038
Acta Biomater. 2021 Mar 15;123:312-324
pubmed: 33508508
Analyst. 2014 Dec 21;139(24):6371-8
pubmed: 25118341
Biomaterials. 2021 Dec;279:121216
pubmed: 34739982
Biomaterials. 2020 Oct;257:120266
pubmed: 32763614
Carbohydr Polym. 2021 Jun 1;261:117878
pubmed: 33766365
Bioact Mater. 2021 Mar 19;6(10):3396-3410
pubmed: 33842736
Adv Healthc Mater. 2021 May;10(10):e2100315
pubmed: 33738988
Adv Healthc Mater. 2019 Feb;8(4):e1801234
pubmed: 30537061
Mater Sci Eng C Mater Biol Appl. 2021 Sep;128:112328
pubmed: 34474879
Cells. 2021 Nov 19;10(11):
pubmed: 34831463
Acta Biomater. 2017 Sep 15;60:181-189
pubmed: 28711686
ACS Appl Mater Interfaces. 2017 Dec 13;9(49):42639-42652
pubmed: 29143524
J Mater Chem B. 2018 Dec 21;6(47):7811-7821
pubmed: 32255027
J Mater Chem B. 2022 Feb 16;10(7):1019-1030
pubmed: 34994756
Int J Biol Macromol. 2020 Oct 1;160:1242-1251
pubmed: 32479939
Acta Biomater. 2019 Jun;91:159-172
pubmed: 31055122
Am J Sports Med. 2018 Aug;46(10):2402-2413
pubmed: 30001494
Adv Healthc Mater. 2021 Jun;10(11):e2100036
pubmed: 33949152
Biomaterials. 2021 Feb;269:120608
pubmed: 33388690
Int J Mol Sci. 2022 Jan 13;23(2):
pubmed: 35055017
J Mol Med (Berl). 2021 Jul;99(7):993-1008
pubmed: 33822264
Gels. 2022 Apr 01;8(4):
pubmed: 35448115
Biomater Sci. 2021 May 18;9(10):3675-3691
pubmed: 33899852
J Control Release. 2020 Nov 10;327:571-583
pubmed: 32905801
Science. 2018 Mar 9;359(6380):1112-1113
pubmed: 29590036
Bioact Mater. 2020 Jun 30;5(4):880-890
pubmed: 32637751
Small. 2022 Jan;18(1):e2104229
pubmed: 34791802
Biomaterials. 2018 Nov;183:93-101
pubmed: 30149233
Biomaterials. 2020 Jan;226:119536
pubmed: 31648135
Int J Biol Macromol. 2019 Apr 1;126:310-317
pubmed: 30502431
ACS Appl Mater Interfaces. 2020 Aug 19;12(33):36978-36995
pubmed: 32814397
Acta Biomater. 2017 Dec;64:176-186
pubmed: 28987783
Int J Mol Sci. 2018 May 24;19(6):
pubmed: 29794976
Stem Cell Res Ther. 2019 Mar 29;10(1):111
pubmed: 30922387
Acta Biomater. 2018 Oct 15;80:1-30
pubmed: 30248515
Adv Drug Deliv Rev. 2021 Jul;174:504-534
pubmed: 33991588
Biomaterials. 2021 Oct;277:121117
pubmed: 34517277
ACS Biomater Sci Eng. 2022 Jan 10;8(1):293-302
pubmed: 34907778
Nat Commun. 2019 Aug 6;10(1):3523
pubmed: 31388014
ACS Appl Mater Interfaces. 2020 Mar 4;12(9):10156-10169
pubmed: 32027477
Adv Healthc Mater. 2019 Jan;8(1):e1801000
pubmed: 30398700
Biomater Sci. 2019 Nov 19;7(12):5221-5231
pubmed: 31595890
Acta Biomater. 2019 Apr 1;88:503-513
pubmed: 30772515
Biomaterials. 2017 May;127:132-140
pubmed: 28268018
Adv Healthc Mater. 2021 Mar;10(6):e2001502
pubmed: 33464711
Biomater Sci. 2021 Apr 7;9(7):2439-2453
pubmed: 33464240
Biomaterials. 2020 Feb;232:119679
pubmed: 31865191
Osteoarthritis Cartilage. 2020 May;28(5):544-554
pubmed: 31926267
Tissue Eng Part A. 2021 Jun;27(11-12):748-760
pubmed: 33108972
Mater Sci Eng C Mater Biol Appl. 2020 Nov;116:111169
pubmed: 32806292
Stem Cell Res Ther. 2021 Dec 4;12(1):591
pubmed: 34863288
Theranostics. 2018 Jan 1;8(4):878-893
pubmed: 29463988
J Mater Chem B. 2021 Sep 29;9(37):7771-7781
pubmed: 34586152
Acta Biomater. 2021 Apr 1;124:191-204
pubmed: 33508511
Int J Nanomedicine. 2020 Aug 14;15:6097-6111
pubmed: 32884266
Acta Biomater. 2019 Dec;100:191-201
pubmed: 31586729
Biomater Sci. 2021 Jun 21;9(12):4228-4245
pubmed: 33522527
J Mater Chem B. 2021 Sep 14;9(34):6856-6869
pubmed: 34396378
Stem Cell Res Ther. 2021 Jun 10;12(1):339
pubmed: 34112263
Acta Biomater. 2019 Sep 1;95:348-356
pubmed: 30831326
Acta Biomater. 2020 Apr 1;106:114-123
pubmed: 32027992
Front Bioeng Biotechnol. 2022 Jan 19;9:829136
pubmed: 35127680
Adv Healthc Mater. 2020 Mar;9(6):e1901761
pubmed: 31999081
Nanoscale. 2017 Mar 30;9(13):4430-4438
pubmed: 28300264
Acta Biomater. 2021 Apr 15;125:253-266
pubmed: 33657452
Adv Healthc Mater. 2021 Apr;10(7):e2001434
pubmed: 33586352

Auteurs

Wenqi Li (W)

School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.
Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines; Engineering Laboratory of Development and Application of Traditional Chinese Medicines; Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.

Jing Hu (J)

School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.
Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines; Engineering Laboratory of Development and Application of Traditional Chinese Medicines; Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.

Cheng Chen (C)

School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.
Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines; Engineering Laboratory of Development and Application of Traditional Chinese Medicines; Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.

Xinyue Li (X)

School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.
Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines; Engineering Laboratory of Development and Application of Traditional Chinese Medicines; Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.

Honghua Zhang (H)

School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.
Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines; Engineering Laboratory of Development and Application of Traditional Chinese Medicines; Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.

Yanru Xin (Y)

School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.
Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines; Engineering Laboratory of Development and Application of Traditional Chinese Medicines; Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.

Qingchang Tian (Q)

School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.
Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines; Engineering Laboratory of Development and Application of Traditional Chinese Medicines; Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.

Shuling Wang (S)

School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.
Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines; Engineering Laboratory of Development and Application of Traditional Chinese Medicines; Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.

Classifications MeSH